Rapid Genome and Exome Sequencing in Inpatients: Clinical Impact at a Tertiary Academic Medical Center
American Journal of Medical Genetics Part A · 2026-06 · 200 (6) · 1337-1346
DOI: 10.1002/ajmg.a.70083 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 17.02.2026. Verfasst von Cecilia M Kessler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Exome Sequencing, Exome, Abnormalities, Multiple, Genome, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Medicine, Vanderbilt University.
Abstract (Originalsprache)
The objective of this study is to describe outcomes of rapid exome (rES) and rapid genome sequencing (rGS) in an inpatient setting. This is a retrospective cohort of inpatients with rES or rGS during their hospitalization between April 2016 and November 2023. Medical records were reviewed to measure primary outcomes: diagnostic yield, medical management changes, and anticipatory guidance updates. Descriptive analysis and formal comparisons (Welch's t ‐test with post hoc power analysis, Fischer's exact test) were performed, with rES and rGS comparisons limited to 2023 due to test distribution. Of 95 patients, most (74.7% [71/95]) were < 12 months old and admitted in neonatal (44.2% [42/95]) or pediatric (29.5% [28/95]) intensive care units. Common indications for rapid sequencing included multiple congenital anomalies (24.2% [23/95]), neurological concerns (23.3% [22/95]), and acute illness (16.8% [16/95]). Mean turnaround time of testing significantly shortened for rES from 2021 (13.2 [SD = 5.9] days) to 2023 (8.1 [SD = 4.1] days) ( p ‐value = 0.018; power = 0.74). Diagnostic yield was 29.5% (28/95) and did not significantly differ between rES (13.6% [3/22]) and rGS (35.0% [7/20]) ( p ‐value = 0.15). Sequencing led to medical management changes (86.0% [74/86]) and anticipatory guidance updates (41.4% [39/95]) with similar rates observed in diagnostic and non‐diagnostic tests. Our findings suggest rES or rGS implementation may influence diagnosis and care strategies in critically ill patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- Division of Medical Genetics and Genomics Medicines, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Division of Quantitative and Clinical Sciences, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Center for Individualized Medicine, Mayo Clinic, Jacksonville, Florida, USA.
ORCID-Profile: Cecilia M Kessler, Elizabeth A Jasper
Förderung
- School of Medicine, Vanderbilt University
Zitieren
APA
Kessler, C. M., Schuler, B. A., Jasper, E. A., Talbert, J., Duncan, L., & Mosera, M. (2026). Rapid Genome and Exome Sequencing in Inpatients: Clinical Impact at a Tertiary Academic Medical Center. American Journal of Medical Genetics Part A, 200(6), 1337-1346. https://doi.org/10.1002/ajmg.a.70083
Vancouver
Kessler CM, Schuler BA, Jasper EA, Talbert J, Duncan L, Mosera M. Rapid Genome and Exome Sequencing in Inpatients: Clinical Impact at a Tertiary Academic Medical Center. American Journal of Medical Genetics Part A. 2026;200(6):1337-1346. doi:10.1002/ajmg.a.70083
BibTeX
@article{Kessler2026,
author = {Kessler, Cecilia M and Schuler, Bryce A and Jasper, Elizabeth A and Talbert, Janet and Duncan, Laura and Mosera, Mackenzie},
title = {Rapid Genome and Exome Sequencing in Inpatients: Clinical Impact at a Tertiary Academic Medical Center},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {6},
pages = {1337--1346},
doi = {10.1002/ajmg.a.70083}
}
EUVIMED